Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia

被引：0
作者：
Nakajima, Asuka [1 ,2 ]
Iwamuro, Hirokazu [3 ]
Tokugawa, Joji [4 ]
Odo, Masahiko [5 ]
Shimo, Yasushi [1 ,2 ]
机构：
[1] Juntendo Univ Nerima Hosp, Dept Neurol, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Res & Therapeut Movement Disorders, Tokyo, Japan
[3] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo, Japan
[4] Juntendo Univ Nerima Hosp, Dept Neurosurg, Tokyo, Japan
[5] Juntendo Univ Nerima Hosp, Dept Anesthesia & Pain Med, Tokyo, Japan
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2023年 / 50卷 / 02期
基金：
日本学术振兴会;
关键词：
Dyskinesia; Propofol; Parkinson's disease; Deep brain stimulation; Cortico-basal ganglia circuits; DOPAMINE TURNOVER;
D O I：
10.1017/cjn.2022.4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [21] Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson's Disease
    Song, Tianbin
    Li, Jiping
    Mei, Shanshan
    Jia, Xiaofei
    Yang, Hongwei
    Ye, Yongquan
    Yuan, Jianmin
    Zhang, Yuqing
    Lu, Jie
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [22] Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
    Kobylecki, Christopher
    Burn, David J.
    Kass-Iliyya, Lewis
    Kellett, Mark W.
    Crossman, Alan R.
    Silverdale, Monty A.
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (04) : 452 - 455
  • [23] Assessment of Parkinson’s disease levodopa-induced dyskinesia: a qualitative research study
    William R. Lenderking
    Sally Mannix
    Jennifer Petrillo
    Christopher Kenney
    Amanda Landrian
    Anette-Eleonore Schrag
    Quality of Life Research, 2015, 24 : 1899 - 1910
  • [24] Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia
    Su, Dongning
    Gan, Yawen
    Zhang, Zhe
    Cui, Yusha
    Zhang, Zhijin
    Liu, Zhu
    Wang, Zhan
    Zhou, Junhong
    Sossi, Vesna
    Stoessl, A. Jon
    Wu, Tao
    Jing, Jing
    Feng, Tao
    MOVEMENT DISORDERS, 2023, 38 (04) : 616 - 625
  • [25] Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson's disease
    Cui, Guiyun
    Yang, Xinxin
    Wang, Xiaoying
    Zhang, Zunsheng
    Yue, Xuanye
    Shi, Hongjuan
    Shen, Xia
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 39 - 46
  • [26] Trial of Dextromethorphan/Quinidine to Treat Levodopa-Induced Dyskinesia in Parkinson's Disease
    Fox, Susan H.
    Metman, Leonard Verhagen
    Nutt, John G.
    Brodsky, Matthew
    Factor, Stewart A.
    Lang, Anthony E.
    Pope, Laura E.
    Knowles, Nadine
    Siffert, Joao
    MOVEMENT DISORDERS, 2017, 32 (06) : 893 - 903
  • [27] Assessment of Parkinson's disease levodopa-induced dyskinesia: a qualitative research study
    Lenderking, William R.
    Mannix, Sally
    Petrillo, Jennifer
    Kenney, Christopher
    Landrian, Amanda
    Schrag, Anette-Eleonore
    QUALITY OF LIFE RESEARCH, 2015, 24 (08) : 1899 - 1910
  • [28] Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?
    Rieck, Mariana
    Schumacher-Schuh, Artur F.
    Callegari-Jacques, Sidia M.
    Altmann, Vivian
    Medeiros, Marcio Schneider
    Rieder, Carlos R. M.
    Hutz, Mara H.
    PHARMACOGENOMICS, 2015, 16 (06) : 573 - 582
  • [29] Incidence and determinants of levodopa-induced dyskinesia in a retrospective cohort of Mexican patients with Parkinson's Disease
    Cervantes-Arriaga, Amin
    Rodriguez-Violante, Mayela
    Salmeron-Mercado, Monica
    Calleja-Castillo, Juan
    Corona, Teresa
    Yescas, Petra
    Alonso-Vilatela, Elisa
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2012, 64 (03): : 220 - 226
  • [30] Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease
    Hashim, H. Z.
    Norlinah, M. I.
    Nafisah, W. Y.
    Tan, H. J.
    Raymond, A. A.
    Tamil, A. M.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (03) : 187 - 191
12345